These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21264878)

  • 1. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
    Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
    J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up.
    Carneiro M; Sanchéz A; Maneiro P; Angelosante W; Pérez C; Valleé M
    Placenta; 2001 Apr; 22 Suppl A():S13-8. PubMed ID: 11312622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common occurrence of anaemia at the end of pregnancy following exposure to zidovudine-free regimens.
    Pinnetti C; Baroncelli S; Molinari A; Nardini G; Genovese O; Ricerca BM; Cavaliere AF; Guaraldi G; Antoni AD; Tamburrini E; Floridia M
    J Infect; 2011 Aug; 63(2):144-50. PubMed ID: 21683094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants.
    Prasitwattanaseree S; Lallemant M; Costagliola D; Jourdain G; Mary JY
    Antivir Ther; 2004 Apr; 9(2):179-85. PubMed ID: 15134179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine administration during pregnancy and mitochondrial disease in the offspring.
    Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M
    Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey.
    Abatemarco DJ; Catov JM; Cross H; Delnevo C; Hausman A
    J Health Care Poor Underserved; 2008 Aug; 19(3):814-28. PubMed ID: 18677072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth outcomes following zidovudine therapy in pregnant women.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1994 Jun; 43(22):409, 415-6. PubMed ID: 8003111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of HIV transmission from mother-to-child in Srinagarind Hospital.
    Sakondhavat C; Kiatchooskul P; Kosalaraksa P; Intarakamhaeng S; Thinkhamrop J; Pinitsoontorn P; Wongkham J; Patoomvivatana P; Thamprisan P; Chaovaratna P; Lueprasert L
    J Med Assoc Thai; 2001 Oct; 84(10):1460-6. PubMed ID: 11804257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infant.
    Limpongsanurak S; Thaithumyanon P; Thisyakorn U; Ruxrungtham K; Chaithongwongwatthana S; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P
    J Med Assoc Thai; 2001 May; 84(5):611-6. PubMed ID: 11560207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.
    de Souza RS; Gómez-Marín O; Scott GB; Guasti S; O'Sullivan MJ; Oliveira RH; Mitchell CD
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):154-61. PubMed ID: 10935691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya.
    Songok EM; Fujiyama Y; Tukei PM; Vulule JM; Kiptoo MK; Adungo NO; Kakimoto K; Kobayashi N; Genga IO; Mpoke S; Ichimura H
    Am J Trop Med Hyg; 2003 Jul; 69(1):8-13. PubMed ID: 12932089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of perinatal transmission of HIV in Arkansas.
    Darville T; Matheney R; Tucker NC
    J Ark Med Soc; 1998 Nov; 95(6):239-41. PubMed ID: 9821745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.